La lecture à portée de main
Editeur
Suivre eisai-europe-limited
Documents
Zonegran® (zonisamida), bien tolerado en el tratamiento prolongado de los niños que padecen epilepsia parcial
Documents
Médias
Zonegran® (zonisamida), bien tolerado en el tratamiento prolongado de los niños que padecen epilepsia parcial
13 pages
Español
Documents
Zonegran® (zonisamide) chez les enfants souffrant de crises d'epilepsie partielles : données cliniques et tolérance favorable confirmées à long terme
Documents
Médias
Zonegran® (zonisamide) chez les enfants souffrant de crises d'epilepsie partielles : données cliniques et tolérance favorable confirmées à long terme
13 pages
Français
Documents
Zonegran® (Zonisamide) Well Tolerated in Long-term Treatment of Children with Partial Epilepsy
Documents
Médias
Zonegran® (Zonisamide) Well Tolerated in Long-term Treatment of Children with Partial Epilepsy
12 pages
English
Documents
Halaven® (Eribulin) Now Commercially Available in Lebanon for the Treatment of Metastatic Breast Cancer
Documents
Médias
Halaven® (Eribulin) Now Commercially Available in Lebanon for the Treatment of Metastatic Breast Cancer
8 pages
English
Documents
Eisai to Collaborate with Liverpool School of Tropical Medicine and University of Liverpool to Discover New Drugs Against Filariasis
Documents
Médias
Eisai to Collaborate with Liverpool School of Tropical Medicine and University of Liverpool to Discover New Drugs Against Filariasis
8 pages
English
Documents
Zonegran® (Zonisamide) Approved for Use in Children and Adolescents by Scottish Medicines Consortium (SMC)
Documents
Médias
Zonegran® (Zonisamide) Approved for Use in Children and Adolescents by Scottish Medicines Consortium (SMC)
10 pages
English
Documents
El Ministerio de Sanidad español autoriza la financiación de Zonegran® (zonisamida) como monoterapia para el tratamiento de la epilepsia en adultos y como terapia coadyuvante en niños y adolescentes
Documents
Médias
El Ministerio de Sanidad español autoriza la financiación de Zonegran® (zonisamida) como monoterapia para el tratamiento de la epilepsia en adultos y como terapia coadyuvante en niños y adolescentes
15 pages
Español
Documents
Epilepsy Treatment Zonegran® (Zonisamide) Receives Reimbursement in Spain as Monotherapy for Adults and Adjunctive Therapy for Children and Adolescents
Documents
Médias
Epilepsy Treatment Zonegran® (Zonisamide) Receives Reimbursement in Spain as Monotherapy for Adults and Adjunctive Therapy for Children and Adolescents
12 pages
English
Documents
Feu vert en Espagne pour le remboursement de Zonegran® (zonisamide) dans deux nouvelles indications du traitement des crises d'épilepsie partielles : en monothérapie chez l'adulte, et en traitement adjuvant chez l'enfant et l'adolescent
Documents
Médias
Feu vert en Espagne pour le remboursement de Zonegran® (zonisamide) dans deux nouvelles indications du traitement des crises d'épilepsie partielles : en monothérapie chez l'adulte, et en traitement adjuvant chez l'enfant et l'adolescent
16 pages
Français
Documents
Fycompa® (Perampanel) to be Resubmitted Early to German Federal Joint Committee (G-BA) for Additional Benefit Assessment
Documents
Médias
Fycompa® (Perampanel) to be Resubmitted Early to German Federal Joint Committee (G-BA) for Additional Benefit Assessment
11 pages
English
Documents
L'essai select de phase III du lenvatinib satisfait à son critère principal: l'amélioration de la survie sans progression dans le traitement du cancer de la thyroïde différencié réfractaire à l'iode radioactif
Documents
Médias
L'essai select de phase III du lenvatinib satisfait à son critère principal: l'amélioration de la survie sans progression dans le traitement du cancer de la thyroïde différencié réfractaire à l'iode radioactif
12 pages
Français
Documents
El ensayo SELECT de fase III de lenvatinib cumple con el criterio principal de valoración de mejora de la supervivencia libre de progresión en el tratamiento de cáncer diferenciado de tiroides refractario al yodo radioactivo
Documents
Médias
El ensayo SELECT de fase III de lenvatinib cumple con el criterio principal de valoración de mejora de la supervivencia libre de progresión en el tratamiento de cáncer diferenciado de tiroides refractario al yodo radioactivo
11 pages
Español
Documents
Once-daily Epilepsy Treatment Zebinix® (Eslicarbazepine Acetate) Now Available with Full Reimbursement in Finland
Documents
Médias
Once-daily Epilepsy Treatment Zebinix® (Eslicarbazepine Acetate) Now Available with Full Reimbursement in Finland
12 pages
English
Documents
Phase III Select Trial of Lenvatinib Meets Primary Endpoint of Improved Progression Free Survival in the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Documents
Médias
Phase III Select Trial of Lenvatinib Meets Primary Endpoint of Improved Progression Free Survival in the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
10 pages
English
Documents
Zonegran® (zonisamide) Reimbursed in Switzerland as Monotherapy Treatment for Adults With Newly Diagnosed Partial Epilepsy
Documents
Médias
Zonegran® (zonisamide) Reimbursed in Switzerland as Monotherapy Treatment for Adults With Newly Diagnosed Partial Epilepsy
11 pages
English
Documents
New First-in-class Epilepsy Treatment Fycompa® (perampanel) Launches in Spain
Documents
Médias
New First-in-class Epilepsy Treatment Fycompa® (perampanel) Launches in Spain
14 pages
English
Documents
Lanzamiento en España de Fycompa® (perampanel), un nuevo tratamiento primero en su clase para la epilepsia
Documents
Médias
Lanzamiento en España de Fycompa® (perampanel), un nuevo tratamiento primero en su clase para la epilepsia
18 pages
Español
Documents
European Commission Grants Orphan Drug Status to Eisai's Amatuximab for the Treatment of Malignant Mesothelioma
Documents
Médias
European Commission Grants Orphan Drug Status to Eisai's Amatuximab for the Treatment of Malignant Mesothelioma
7 pages
English
Documents
Life-extending Metastatic Breast Cancer Treatment Now Available in the Republic of Ireland
Documents
Médias
Life-extending Metastatic Breast Cancer Treatment Now Available in the Republic of Ireland
12 pages
English
Documents
Innovative Metastatic Breast Cancer Treatment Halaven® (Eribulin) Recieves Reimbursement Approval in the Czech Republic
Documents
Médias
Innovative Metastatic Breast Cancer Treatment Halaven® (Eribulin) Recieves Reimbursement Approval in the Czech Republic
10 pages
English
Documents
Inovelon® (Rufinamide) Oral Suspension Formulation Launched in Portugal
Documents
Médias
Inovelon® (Rufinamide) Oral Suspension Formulation Launched in Portugal
9 pages
English
Documents
Eisai's Named Patient Access Programme for Fycompa® (perampanel) Available from 1 January 2014
Documents
Médias
Eisai's Named Patient Access Programme for Fycompa® (perampanel) Available from 1 January 2014
11 pages
English
Documents
Eisai anuncia nueva colaboración con Esteve para la promoción del fármaco contra la epilepsia Zonegran® (Zonisamida) en España
Documents
Médias
Eisai anuncia nueva colaboración con Esteve para la promoción del fármaco contra la epilepsia Zonegran® (Zonisamida) en España
13 pages
Español
Documents
Eisai Announces New Partnership with Esteve to Promote Anti-epilepsy Drug Zonegran® (Zonisamide) in Spain
Documents
Médias
Eisai Announces New Partnership with Esteve to Promote Anti-epilepsy Drug Zonegran® (Zonisamide) in Spain
10 pages
English
Documents
EISAI annonce un nouvel accord de partenariat avec Esteve pour la promotion de son médicament antiépileptique Zonegran® (Zonisamide) en Espagne
Documents
Médias
EISAI annonce un nouvel accord de partenariat avec Esteve pour la promotion de son médicament antiépileptique Zonegran® (Zonisamide) en Espagne
12 pages
Français
Documents
Eisai Presents New Data Analyses on Fycompa® (Perampanel) at American Epilepsy Society Annual Meeting
Documents
Médias
Eisai Presents New Data Analyses on Fycompa® (Perampanel) at American Epilepsy Society Annual Meeting
8 pages
English
Documents
Eisai Oncology to Present Data Analyses on Halaven® (eribulin) at 36th Annual San Antonio Breast Cancer Symposium
Documents
Médias
Eisai Oncology to Present Data Analyses on Halaven® (eribulin) at 36th Annual San Antonio Breast Cancer Symposium
8 pages
English
Documents
First-In-Class Treatment Fycompa® (Perampanel) Launched in Finland for Most Common Form of Epilepsy
Documents
Médias
First-In-Class Treatment Fycompa® (Perampanel) Launched in Finland for Most Common Form of Epilepsy
14 pages
English
Documents
Cancer Cookbook Promotes the Positive Power of Food for People in Treatment
Documents
Médias
Cancer Cookbook Promotes the Positive Power of Food for People in Treatment
8 pages
English
Documents
Eisai Joins Ground-Breaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Treatments
Documents
Médias
Eisai Joins Ground-Breaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Treatments
6 pages
English